Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-07-12
1997-12-09
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 11, 514 16, 514 17, 514 18, 514 19, 514269, A61K 31505, A61K 3155, A61K 3804
Patent
active
056961162
ABSTRACT:
A pharmaceutical composition suitable for the treatment of cardiovascular disorders is described which comprises an inhibitor of the Renin Angiotensin System and an endothelin antagonist.
REFERENCES:
patent: 4248883 (1981-02-01), Sawayama et al.
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4385051 (1983-05-01), Oka et al.
patent: 4410520 (1983-10-01), Watthey
patent: 4470972 (1984-09-01), Gold et al.
patent: 4658024 (1987-04-01), Attwood et al.
patent: 4859665 (1989-08-01), Garthoff, et al.
patent: 5324839 (1994-06-01), Clemence et al.
patent: 5338726 (1994-08-01), Shiosaki et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5420123 (1995-05-01), Murugesan
Thomas Hedner et al., Journal of Hypertension, vol. 10, Supp. 7, pp. 121-132, (1992).
Abstract (corresponding to EP 0065301, Nov. 1982).
Clozel Jean-Paul
Clozel Martine
Osterrieder, deceased Wolfgang Robert
Ciambrone Coletti Ellen
Hoffmann-La Roche Inc.
Johnston George W.
Russel Jeffrey E.
LandOfFree
Pharmaceutical composition which contains a renin angiotensin sy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition which contains a renin angiotensin sy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition which contains a renin angiotensin sy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607869